Search results
GNRC & CPower Partner to Transform Energy Resilience & Revenue in PJM
As electricity demand surges and power prices rise, businesses are increasingly seeking smarter, more resilient energy solutions. In response to this evolving landscape, Generac Holdings Inc. GNRC
Is Coherent's Product Range Positioning It as a Premium AI Asset?
Coherent Corp. COHR registered 33.5% year-over-year growth in its datacenter & communications segment’s revenues in the second quarter of fiscal 2026. This segment generated 72% of the top line, a
DELL Gains From Commercial PC Demand: Can it Boost CSG Growth?
Dell Technologies DELL is benefiting from robust commercial PC demand, which has significantly contributed to the growth of its Client Solutions Group (“CSG”). In the fourth quarter of fiscal 2026
Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?
Making its debut on 03/11/2013, smart beta exchange traded fund Global X SuperDividend U.S. ETF (DIV) provides investors broad exposure to the Style Box - All Cap Value category of the market.
What
Wall Street's Insights Into Key Metrics Ahead of The PNC Financial Services Group (PNC) Q1 Earnings
Wall Street analysts forecast that The PNC Financial Services Group, Inc (PNC) will report quarterly earnings of $4.10 per share in its upcoming release, pointing to a year-over-year increase of
Is ADMA Poised for Margin Growth and Supply Expansion in 2026?
ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases.
Gross margin improved to 57.4% in 2025 from 51.5% in
Space Race 2.0: AI's Trillion-Dollar Escape Plan
The digital gold rush for artificial intelligence (AI) has an unseen, physical cost. The insatiable appetite of AI for processing power is creating a direct and growing strain on global energy and
Is Fidelity Quality Factor ETF (FQAL) a Strong ETF Right Now?
Making its debut on 09/12/2016, smart beta exchange traded fund Fidelity Quality Factor ETF (FQAL) provides investors broad exposure to the Style Box - Large Cap Blend category of the market.
What
Shopify's Subscription Growth Accelerates: More Upside Ahead?
Shopify’s SHOP prospects benefit from robust Subscription Solutions segment revenues, which contributed 21.2% to the total revenues in the fourth quarter of 2025. Subscription Solutions revenues
Is Invesco S&P MidCap 400 Pure Value ETF (RFV) a Strong ETF Right Now?
Making its debut on 03/01/2006, smart beta exchange traded fund Invesco S&P MidCap 400 Pure Value ETF (RFV) provides investors broad exposure to the Style Box - Mid Cap Value category of the market.
Buy These 4 High-Efficiency Stocks Beating Peers on Profitability
Efficiency level assesses a company’s capability to transform usable input into output, and is commonly considered an essential parameter for gauging its potential to generate profits. A company
Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?
Danish drugmaker Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its blockbuster semaglutide-based (GLP-1) drugs — Ozempic (for type II
Should You Buy, Sell or Hold FCX Stock After a 20% YTD Rally?
Freeport-McMoRan Inc.’s FCX shares have popped 20.2% year to date, thanks to its strong fourth-quarter earnings performance and an uptick in copper prices, driven by concerns over tighter global
Equinor Shares Rally Toward 52-Week High: Buy the Strength or Wait?
Equinor ASA EQNR shares are rapidly climbing toward their 52-week high of $43.46, closing at $42.07 on April 7. EQNR is an integrated energy company headquartered in Norway. Its operations span
NIKE Hits 52-Week Low: Buy Opportunity or Time To Be Wary?
Shares of NIKE Inc. NKE hit a new 52-week low of $42.36 yesterday, before rising a notch higher to close at $42.69. The stock has been volatile in recent months, highlighting weakening demand
Hensoldt Aktie: Trügerischer Rekord!
Die Auftragsbücher quellen über, das Management verspricht eine höhere Dividende – und trotzdem trennen…
Der Beitrag Hensoldt Aktie: Trügerischer Rekord! erschien zuerst auf kapitalmarktexperten.de.
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
Merck MRK and its Japanese partner Daiichi Sankyo announced that the FDA has accepted the biologics license application (BLA) seeking approval for ifinatamab deruxtecan (I-DXd), a B7-H3-directed DXd
Dominion Minerals Ltd.
WKN: A3C6E9 / Name: Dominion Minerals / Stock / Biotechnology & Medical Research / Micro Cap /



